Jeff Gross

Earnings Watch: Lockheed Martin Corporation (NYSE:LMT)

Lockheed Martin Corporation (NYSE:LMT) plunged -0.27% or -0.69 points during previous trade after opening at the price of $257.78, a total of 2.34M shares exchanged hands compared with its average trading volume of 1.82M shares. The stock has a market capitalization of $78.12B and it has 304.45M outstanding shares.

According to consensus agreement of 16 analysts Lockheed Martin Corporation (NYSE:LMT) will report earnings per share of $2.93 in their quarterly report and it is expected to announce the company’s results on 7/19/2016 BMO. For the current quarter the company has highest EPS estimates of $3 and low forecast is $2.83. However a year ago for the same quarter the company has reported $2.94 earnings per share.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 3/2016, the consensus mean EPS was $2.51 while the company reported $2.58 EPS on 4/26/2016 BMO with a difference of 0.07 marking a surprise factor of 2.79%.

Previously for the quarter ended on 12/2015, Lockheed Martin Corporation (NYSE:LMT)’s expected mean EPS was $2.93, the company reported its quarterly earnings per share of $3.01 on 1/26/2016 BMO, beating the analysts’ consensus estimate by 0.08 with surprise factor of 2.73%.

Lockheed Martin Corporation (NYSE:LMT)’s mean EPS estimate was $2.70 for the quarter ended on 9/2015, while it reported EPS of $2.77 on 10/20/2015 BMO, beating the analysts’ consensus estimate by 0.07 with surprise factor of 2.59%.

Back on 7/20/2015 the company’s estimated EPS value was $2.67 and it reported $2.94 earnings per share (EPS) for the quarter ended on 6/2015. The company posted a positive surprise factor of 10.11% by 0.27.

Lockheed Martin Corporation (NYSE:LMT)’s average EPS forecast for the current year is $11.85 according to 19 analysts making projections. The most expectant earnings per share estimate of the stock is set at $12.05 while the conservative estimates kept at $11.17 over the current year. Having a look at the historical EPS report, the company attained $11.32 EPS for the previous year. While revenue estimates for the current year is 50.46B, setting the highest revenues estimates of 49.53B and indicating lowest revenues at 4.53B according to agreement of 17 number of analysts. Current revenue movements show that, the company has set average revenue estimates of 12.56B covering forecast of 13 analysts. The company indicates a peak revenue level of 12.86B and 12.19B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -0.30% whereas for next quarter it has 8.30% estimations over growth. Its forecasts over growth are 4.70% during current year while analysts’ growth estimation for the next year is 16.50%. Past 5 years growth of Lockheed Martin Corporation (NYSE:LMT) observed at 9.78%, and for the next five years the analysts that follow this company are expecting its growth at 10.36%.

Lockheed Martin Corporation (NYSE:LMT) reached at $256.29 price level during last trade its distance from 20 days simple moving average is 3.89%, and its distance from 50 days simple moving average is 5.77% while it has a distance of 15.55% from the 200 days simple moving average. On year trading price range hit the peak level of $258.29 and touched the lowest level of $181.91 and its distance from 52 week high is -0.64% and current price is above +45.04% from 52 week low.

Stock Estimates Under Consideration: MGIC Investment Corp. (NYSE:MTG)

MGIC Investment Corp. (NYSE:MTG) plunged -0.16% or -0.01 points during previous trade after opening at the price of $6.40, a total of 5.56M shares exchanged hands compared with its average trading volume of 7.32M shares. The stock has a market capitalization of $2.17B and it has 340.64M outstanding shares.

According to consensus agreement of 14 analysts MGIC Investment Corp. (NYSE:MTG) will report earnings per share of $0.2 in their quarterly report and it is expected to announce the company’s results on 7/19/2016 BMO. For the current quarter the company has highest EPS estimates of $0.22 and low forecast is $0.15. However a year ago for the same quarter the company has reported $0.28 earnings per share.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 3/2016, the consensus mean EPS was $0.23 while the company reported $0.19 EPS on 4/19/2016 BMO with a difference of -0.04 marking a surprise factor of 17.39%.

Previously for the quarter ended on 12/2015, MGIC Investment Corp. (NYSE:MTG)’s expected mean EPS was $0.25, the company reported its quarterly earnings per share of $0.26 on 1/21/2016 BMO, beating the analysts’ consensus estimate by 0.01 with surprise factor of 4.00%.

MGIC Investment Corp. (NYSE:MTG)’s mean EPS estimate was $0.22 for the quarter ended on 9/2015, while it reported EPS of $0.29 on 10/15/2015 BMO, beating the analysts’ consensus estimate by 0.07 with surprise factor of 31.82%.

Back on 7/16/2015 the company’s estimated EPS value was $0.23 and it reported $0.28 earnings per share (EPS) for the quarter ended on 6/2015. The company posted a positive surprise factor of 21.74% by 0.05.

MGIC Investment Corp. (NYSE:MTG)’s average EPS forecast for the current year is $0.77 according to 12 analysts making projections. The most expectant earnings per share estimate of the stock is set at $0.85 while the conservative estimates kept at $0.7 over the current year. Having a look at the historical EPS report, the company attained $1.09 EPS for the previous year. While revenue estimates for the current year is 1.03B, setting the highest revenues estimates of 1.06B and indicating lowest revenues at1.01B according to agreement of 9 number of analysts. Current revenue movements show that, the company has set average revenue estimates of 255.01M covering forecast of 9 analysts. The company indicates a peak revenue level of 261M and 249.89M at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -28.60% whereas for next quarter it has -31.00% estimations over growth. Its forecasts over growth are -29.40% during current year while analysts’ growth estimation for the next year is 22.10%. Past 5 years growth of MGIC Investment Corp. (NYSE:MTG) observed at 105.77%, and for the next five years the analysts that follow this company are expecting its growth at 1.87%.

MGIC Investment Corp. (NYSE:MTG) reached at $6.38 price level during last trade its distance from 20 days simple moving average is 6.03%, and its distance from 50 days simple moving average is -0.36% while it has a distance of -17.32% from the 200 days simple moving average. On year trading price range hit the peak level of $11.46 and touched the lowest level of $5.36 and its distance from 52 week high is -45.05% and current price is above +19.03% from 52 week low.

Johnson & Johnson (NYSE:JNJ): Can the Stock Surprise in Next Earnings?

Johnson & Johnson (NYSE:JNJ) soared 0.11% or +0.14 points during previous trade after opening at the price of $123.00, a total of 6.60M shares exchanged hands compared with its average trading volume of 7.48M shares. The stock has a market capitalization of $338.22B and it has 2.75M outstanding shares.

According to consensus agreement of 19 analysts Johnson & Johnson (NYSE:JNJ) will report earnings per share of $1.68 in their quarterly report and it is expected to announce the company’s results on 7/19/2016BMO. For the current quarter the company has highest EPS estimates of $1.71 and low forecast is $1.63. However a year ago for the same quarter the company has reported $1.71 earnings per share.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 3/2016, the consensus mean EPS was $1.64 while the company reported $1.68 EPS on 4/19/2016BMO with a difference of 0.04 marking a surprise factor of 2.44%.

Previously for the quarter ended on 12/2015, Johnson & Johnson (NYSE:JNJ)’s expected mean EPS was $1.42, the company reported its quarterly earnings per share of $1.44 on 1/26/2016BMO, beating the analysts’ consensus estimate by 0.02 with surprise factor of 1.41%.

Johnson & Johnson (NYSE:JNJ)’s mean EPS estimate was $1.44 for the quarter ended on 9/2015, while it reported EPS of $1.49 on 10/13/2015BMO, beating the analysts’ consensus estimate by 0.05 with surprise factor of 3.47%.

Back on 7/14/2015the company’s estimated EPS value was $1.69 and it reported $1.71 earnings per share (EPS) for the quarter ended on 6/2015. The company posted a positive surprise factor of 1.18% by 0.02.

Johnson & Johnson (NYSE:JNJ)’s average EPS forecast for the current year is $6.61 according to 22 analysts making projections. The most expectant earnings per share estimate of the stock is set at $6.7 while the conservative estimates kept at $6.55 over the current year. Having a look at the historical EPS report, the company attained $6.2 EPS for the previous year. While revenue estimates for the current year is 71.73B, setting the highest revenues estimates of 70.07B and indicating lowest revenues at71.47 B according to agreement of 21 number of analysts. Current revenue movements show that, the company has set average revenue estimates of 17.98B covering forecast of 16 analysts. The company indicates a peak revenue level of 18.2B and 17.74B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -1.80% whereas for next quarter it has 11.40% estimations over growth. Its forecasts over growth are 6.60% during current year while analysts’ growth estimation for the next year is 6.10%. Past 5 years growth of Johnson & Johnson (NYSE:JNJ) observed at 5.31%, and for the next five years the analysts that follow this company are expecting its growth at 6.11%.

Johnson & Johnson (NYSE:JNJ) reached at $123.14 price level during last trade its distance from 20 days simple moving average is 2.63%, and its distance from 50 days simple moving average is 5.76% while it has a distance of 16.56% from the 200 days simple moving average. On year trading price range hit the peak level of $124.30 and touched the lowest level of $81.79 and its distance from 52 week high is -0.93% and current price is above +53.86% from 52 week low.

Experts Analysis on Price Reaction History: Antero Resources Corp (NYSE:AR)

Antero Resources Corp (NYSE:AR) plunged -1.79% during previous trade, a total of 3.34M shares exchanged hands compared with its average trading volume of 4.59M shares. The stock has a market capitalization of $7.88B along with 304.16M outstanding shares. On year trading price range hit the peak level of $31.45 and touched the lowest level of $18.50.

Most recently the company’s price target was revised on 07/15/16 and according to 28 analysts stock’s price will reach at $32.61 during 52 weeks with standard deviation of 4.78. Stock’s minimum price target estimates has been figured out at $24.00 while the maximum price target forecast is established at $41.00, if we look at the price target with an optimistic approach it has upside potential of 55% from its latest closing price of $26.37.

Historically, if we look at price target revisions during last one month, three weeks ago stock’s price target was revised on 06/14/16 by the analysts. The bullish price estimates of the stock is set at $42.00 while the bearish estimates kept at $24.00 over the next one year. Stock’s 52-week target was retained at $31.78, the estimates indicates a standard deviation of 4.56. After that the stock’s target price was revised on 06/27/16, approximately two weeks ago. Antero Resources Corp (NYSE:AR) highest price target was set at $42.00 and lowest target was at $24.00. The company’s one year price target was secure at $31.89 and its standard deviation of 4.71. Moreover one week ago on 07/07/16 the company’s price target was revised at $31.89 with 52 week price target range of $42.00 – $24.00. The estimates signifies a standard deviation of 4.64.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.25. ABR value is precisely based on brokerage recommendations, where out of 20 brokerage recommendations 7 rate Antero Resources Corp (NYSE:AR) stock a Strong Buy, 2 rate the stocks of the company a Buy, 10 rate Hold, 1 rate Sell and 0 recommend a Strong Sell. Most recently on 4/15/2016 the stock of Antero Resources Corp (NYSE:AR) upgraded by Tudor Pickering from Hold to Buy. However previously on 4/15/2016 it was upgraded by JP Morgan from Underweight to Neutral. A research note issued on 3/10/2016 the stock was downgraded by Robert W. Baird from Outperform to Neutral.

Antero Resources Corp (NYSE:AR) performance over the past one year plunged -16.42%, during the last six months the stock rose 27.64%. Quarterly performance of the company shows declining momentum of -1.75% while its last one month trend is negative with -5.75%. Stock’s weekly performance expressed up trend of 2.61%.

According to consensus agreement of 29 analysts Antero Resources Corp (NYSE:AR) will report earnings per share of $0.12 in their quarterly report and it is expected to announce the company’s results on 8/2/2016 AMC. For the current quarter the company has high EPS estimates of $0.19 in contradiction of low EPS estimates of $0.02. However a year ago for the same quarter the company has reported $0.06 EPS.

How Big Insider Trading Can Impact Illumina, Inc. (NASDAQ:ILMN) Stock?

Illumina, Inc. (NASDAQ:ILMN) stock exchanged hands 787,739.00 shares versus average trading capacity of 1.21M shares, while its shares total market worth is $22.11B along with 147.20M outstanding shares. Its shares ended last trading session at the price of $148.71 whereas a number of traders indicating mean target price will hit $153.53 over the next twelve months, mean value of price target most recently revised on 07/05/16. The highest estimates of price target are $185.00 and low forecast is $110.00 based on the opinion of 19 analysts. The price target estimates represents a standard deviation of 30.38. However brokerage recommendations suggests an ABR of 2.62 based on calls of 15 experts, where 3 brokers polls the stock a Strong Buy, 1 suggest the stock a Buy, 10 suggest Hold, 0 are rating the stock as Sell while 1 as Strong Sell.

The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. Total 21 number of trades held during last 3 months and 170 during last 12 months, out of them 7 numbers of buys held in last 3 months and 33 buys in last 12 months. Whereas 14 numbers of sells held in last 3 months and 137 sells over the past 12 months.

Insiders has most recently took part in a trading activity, Bowman A Blaine, Director of the company in a transaction that occurred 7/14/2016   sold 100 shares of the stock. The stock was sold at a price of $148.34, for a total value of $14,834. Subsequent to the transaction Bowman A Blaine owned a total of 15,704 shares of the stock.

In a separate transaction on 7/14/2016, Bowman A Blaine, Director sold 2,606 shares of the stock. The stock was sold at a price of $146.79, for a total worth of $382,527. Succeeding to the transaction Bowman A Blaine owned overall 18,098 shares of the stock.

Moreover, Bowman A Blaine, Director sold 2,294 shares of the stock in a reserved transaction that ensued on 7/14/2016. At a price of $147.49, the stock was sold for an entire value of $338,344. Consequent to the transaction Bowman A Blaine owned a total of 15,804 shares of the stock.

Currently, 1.20% shares of Illumina, Inc. (NASDAQ:ILMN) are owned by insiders with -9.21% six-month change in the insider ownership. According to U.S. Security Exchange Commission Filing, Walt David R is one of the major insider shareholder of the company’s stock, the insider owns 631,840 shares reported on Apr 7, 2016. Flatley Jay T is second leading insider shareholder, as of Apr 12, 2016 the insider owns 488,061 shares of the stock. Orpin Tristan is another major insider shareholder of the stock, as per record date of Mar 8, 2016 insider owns 118,956 shares of the stock.

Illumina, Inc. (NASDAQ:ILMN) is expected to release the earnings of its current quarter on 7/26/2016 AMC. The company is expected to release $0.73 EPS during current quarter according to 22 analysts whereas the company reported $0.8 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.72 and high estimate of $0.74. Illumina, Inc. (NASDAQ:ILMN)’s average revenue estimates for the current quarter are 593.11M according to 20 number of analysts. However its lowest revenue estimates are 589.79M and highest revenue estimates are 595M. A year ago the company’s sales were 539.38M. Its yearly sales growth estimates are 10.00%.

A Look at Insider Trading: Global Payments Inc (NYSE:GPN)

Global Payments Inc (NYSE:GPN) stock exchanged hands 816,897 shares versus average trading capacity of 1.37M shares, while its shares total market worth is $11.85B along with 154.00M outstanding shares. Its shares ended last trading session at the price of $76.72 whereas a number of traders indicating mean target price will hit $78.36 over the next twelve months, mean value of price target most recently revised on 07/12/16. The highest estimates of price target are $90.00 and low forecast is $64.00 based on the opinion of 22 analysts. The price target estimates represents a standard deviation of 6.07. However brokerage recommendations suggests an ABR of 2.18 based on calls of 22 experts, where 9 brokers polls the stock a Strong Buy, 2 suggest the stock a Buy, 10 suggest Hold, 0 are rating the stock as Sell while 1 as Strong Sell.

The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. Total 9 number of trades held during last 3 months and 72 during last 12 months, out of them 5 numbers of buys held in last 3 months and 22 buys in last 12 months. Whereas 4 numbers of sells held in last 3 months and 50 sells over the past 12 months.

Insiders has most recently took part in a trading activity, Jacobs William I, Director of the company in a transaction that occurred 7/13/2016   sold 600 shares of the stock. The stock was sold at a price of $75.80, for a total value of $45,480. Subsequent to the transaction Jacobs William I owned a total of 44,716 shares of the stock.

In a separate transaction on 6/30/2016, Bready Cameron M, Executive VP and CFO sold 6,228     shares of the stock. The stock was sold at a price of $71.38, for a total worth of $444,555. Succeeding to the transaction Bready Cameron M owned overall 52,648 shares of the stock.

Moreover, Jacobs William I, Director sold 10 shares of the stock in a reserved transaction that ensued on 6/13/2016. At a price of $73.69, the stock was sold for an entire value of $737. Consequent to the transaction Jacobs William I owned a total of 45,906 shares of the stock.

Currently, 0.40% shares of Global Payments Inc (NYSE:GPN) are owned by insiders with -1.77% six-month change in the insider ownership. According to U.S. Security Exchange Commission Filing, Baldwin Robert H B JR is one of the major insider shareholder of the company’s stock, the insider owns 368,565 shares reported on Apr 22, 2016. Sloan Jeffrey Steven is second leading insider shareholder, as of Oct 1, 2015 the insider owns 117,894 shares of the stock. Mangum David E is another major insider shareholder of the stock, as per record date of Aug 18, 2015 insider owns 81,917 shares of the stock.

Global Payments Inc (NYSE:GPN) is expected to release the earnings of its current quarter on 7/28/2016 BMO. The company is expected to release $0.73 EPS during current quarter according to 26 analysts whereas the company reported $0.61 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.77 and high estimate of $0.68. Global Payments Inc (NYSE:GPN)’s average revenue estimates for the current quarter are 574.38M according to 20 number of analysts. However its lowest revenue estimates are 508.9M and highest revenue estimates are 645.5M. A year ago the company’s sales were 706.55M. Its yearly sales growth estimates are -18.70%.

Eye Catching Insider Trading and Recommendations: SYSCO Corporation (NYSE:SYY)

SYSCO Corporation (NYSE:SYY) stock exchanged hands2.41M shares versus average trading capacity of 4.08M shares, while its shares total market worth is $563.52M along with 563.52M outstanding shares. Its shares ended last trading session at the price of $52.02 whereas a number of traders indicating mean target price will hit $50.44 over the next twelve months, mean value of price target most recently revised on 07/13/16. The highest estimates of price target are $55.00 and low forecast is $44.00 based on the opinion of 9 analysts. The price target estimates represents a standard deviation of 5.03. However brokerage recommendations suggests an ABR of 2.41 based on calls of 8 experts, where 3 brokers polls the stock a Strong Buy, 0 suggest the stock a Buy, 4 suggest Hold, 0 are rating the stock as Sell while 1 as Strong Sell.

The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. Total 30 number of trades held during last 3 months and 126 during last 12 months, out of them 17 numbers of buys held in last 3 months and 76 buys in last 12 months. Whereas 13 numbers of sells held in last 3 months and 50 sells over the past 12 months.

Insiders has most recently took part in a trading activity, Grade Joel T, EVP and CFO of the company in a transaction that occurred 7/13/2016   sold 16,398 shares of the stock. The stock was sold at a price of $52.01, for a total value of $851,300. Subsequent to the transaction Grade Joel T owned a total of 43,663 shares of the stock.

In a separate transaction on 7/5/2016, Grade Joel T, EVP and CFO sold 16,398 shares of the stock. The stock was sold at a price of $51.00, for a total worth of $836,298. Succeeding to the transaction Grade Joel T owned overall 42,623 shares of the stock.

Moreover, Grade Joel T, EVP and CFO sold 16,428 shares of the stock in a reserved transaction that ensued on 6/17/2016. At a price of $49.96, the stock was sold for an entire value of $820,743. Consequent to the transaction Grade Joel T owned a total of 41,614 shares of the stock.

Currently, 0.30% shares of SYSCO Corporation (NYSE:SYY) are owned by insiders with -21.12% six-month change in the insider ownership. According to U.S. Security Exchange Commission Filing, Peltz Nelson is one of the major insider shareholder of the company’s stock, the insider owns 5,648 shares reported on Jun 30, 2016. Frank Joshua D. is second leading insider shareholder, as of Jun 30, 2016 the insider owns 5,648 shares of the stock. Delaney William J III is another major insider shareholder of the stock, as per record date of Jun 15, 2016 insider owns 402,393 shares of the stock.

SYSCO Corporation (NYSE:SYY) is expected to release the earnings of its current quarter on 8/15/2016 BMO. The company is expected to release $0.61 EPS during current quarter according to 12 analysts whereas the company reported $0.52 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.58 and high estimate of $0.65. SYSCO Corporation (NYSE:SYY)’s average revenue estimates for the current quarter are 13.66B according to 11 number of analysts. However its lowest revenue estimates are 13.56B and highest revenue estimates are 13.9B. A year ago the company’s sales were 12.4B. Its yearly sales growth estimates are 10.20%.

Healthcare Stocks in Focus: Mylan NV (NASDAQ:MYL), Hologic, Inc. (NASDAQ:HOLX)

Mylan NV (NASDAQ:MYL) shares went up 0.15% or +0.07 points to reach at $45.45 during the course of session. The stock traded in the range of $45.15 – $45.90 during its most recent trading session. The stock has total market worth of $23.11B and it has total of 508.37M outstanding shares. Relative strength index (RSI-14) for Mylan NV (NASDAQ:MYL) is at 60.82.

Historically the stock has climbed 2.04% in the past week and soared 1.59% in the last four weeks, the stock illustrate that its three months performance stands at -3.07% while its year to date performance is at -15.94%. Stock’s price oscillated from $70.81 to $37.59 during past twelve months. The stock is now trading at a distance of 2.78% from SMA-20. The stock is presently trading 4.90% above from its SMA-50. In the current trading session, the stock’s price moved -2.59% below from its SMA-200. If we take a look on its volatility, 1.85 percent was seen in a week and for the month it was 2.53 percent. Stock’s beta value stands at 1.23 and its ATR value is at 1.19.

Mylan NV (NASDAQ:MYL) on July 11, 2016 announced the U.S. launch of Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is a generic version of Merck’s Temodar®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product. Temozolomide Capsules are indicated for the treatment of adult patients with newly diagnosed cancerous tumors known as glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment.

Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, had U.S. sales of approximately $176.5 million for the 12 months ending May 31, 2016, according to IMS Health.

Currently, Mylan has 246 ANDAs pending FDA approval representing $107.4 billion in annual brand sales, according to IMS Health. Forty-three of these pending ANDAs are potential first-to-file opportunities, representing $37.2 billion in annual brand sales, for the 12 months ending December 31, 2015, according to IMS Health.

Hologic, Inc. (NASDAQ:HOLX) shares slipped -0.49% or -0.18 points in order to take the company’s stock at the price of $36.35. Stock’s price oscillated between $36.93 and $36.31 for intra-day trading. Relative strength index (RSI-14) for Hologic, Inc. (NASDAQ:HOLX) is at 63.63. It has total market capitalization of $10.34B.

Historically the stock has climbed 1.17% in the past week and soared 9.72% in the last four weeks, the stock illustrate that its three months performance stands at 0.50% while its year to date performance is at -6.05%. The stock hit the peak level of one year at $43.00 and touched the minimum level of $31.84. Shares are trading -15.47% off from the 52-week high and +14.16% above from the 52-week bottom level. The stock is now trading at a distance of 4.85% from SMA-20. The stock is presently trading 6.24% above from its SMA-50. In the current trading session, the stock’s price moved 0.56% above from its SMA-200. The company has a Return on Assets of 2.70%. The company currently has a Return on Equity of 9.80% and a Return on Investment of 6.10%.

Hologic, Inc. (NASDAQ:HOLX) on July 5, 2016 announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms of the base indenture governing the notes dated as of December 10, 2007, as supplemented by the second supplemental indenture dated as of November 23, 2010 (collectively, the indenture).

The conversion right has been triggered because the closing price of the Company’s common stock exceeded approximately $29.94, which is 130% of the conversion price for the notes, for at least 20 of the 30 consecutive trading days ending on June 30, 2016.  As a result, the notes are convertible until September 30, 2016 subject to the terms, conditions and adjustments in the indenture and the notes.  The notes may continue to be convertible after September 30, 2016 if one or more conditions specified in the indenture are satisfied during future measurement periods.

The current conversion rate for the notes is 43.4216 shares of the Company’s common stock per $1,000 principal amount outstanding, which is equivalent to a conversion price, as defined in the indenture, of approximately $23.03 per share.  The Company may elect to satisfy its conversion obligation in shares of common stock, cash, or a combination of cash and shares in accordance with the terms, procedures and conditions outlined in the indenture and the notes.

None of the Company, its board of directors, or employees has made, or is making, any representation or recommendation to any holder of the notes as to whether or not to exercise the conversion right.

Technology Stocks in the Spotlight: International Business Machines Corp. (NYSE:IBM), Cypress Semiconductor Corporation (NASDAQ:CY)

International Business Machines Corp. (NYSE:IBM) shares went down -0.31% or -0.50 points to reach at $159.78 during the course of session. The stock traded in the range of $158.50 – $159.98 during its most recent trading session. The stock has total market worth of $155.58B and it has total of 959.96M outstanding shares. Relative strength index (RSI-14) for International Business Machines Corp. (NYSE:IBM) is at 67.24.

Historically the stock has climbed 3.44% in the past week and soared 6.04% in the last four weeks, the stock illustrate that its three months performance stands at 6.33% while its year to date performance is at 18.42%. Stock’s price oscillated from $116.90 to $116.90 during past twelve months. The stock is now trading at a distance of 4.80% from SMA-20. The stock is presently trading 5.85% above from its SMA-50. In the current trading session, the stock’s price moved 13.94% above from its SMA-200. If we take a look on its volatility, 1.11 percent was seen in a week and for the month it was 1.44 percent. Stock’s beta value stands at 0.76 and its ATR value is at 2.23.

International Business Machines Corp. (NYSE:IBM) on July 14, 2016 announced a cloud service for organizations requiring a secure environment for blockchain networks. Ideal for organizations in regulated industries, this environment allows clients to test and run blockchain projects that handle private data.

IBM’s secure blockchain cloud environment, underpinned by IBM LinuxONE, the industry’s most secure Linux-only server, are ideal for organizations such as Everledger, a company that tracks and protects diamonds and other valuables via the blockchain.1 Everledger is building a digital business network using IBM Blockchain to power its global certification system to track valuable items through the supply chain, helping to protect suppliers, buyers and shippers against theft, counterfeiting and other forms of corruption. The blockchain is used to demonstrate the origin of high-value goods such as diamonds, fine art and luxury goods.

As blockchain grows in influence and organizations begin to evaluate cloud-based production environments for their first blockchain projects, they are exploring ways to maximize the security and compliance of the technology for business-critical applications. The average total cost of a data breach for enterprises reached $4 million last year, and with security incidents up by 64 percent in 2015, the risks are higher than ever.2 Security is critical – not just within the blockchain itself but with all the technology touching the ledger.

The business network on the IBM Blockchain cloud environment helps secure entry points and fight against insider threats. With advanced features that help protect data and ensure the integrity of the overall network, LinuxONE is designed to meet the stringent security requirements of the financial, health care and government sectors, helping to foster compliance.

Cypress Semiconductor Corporation (NASDAQ:CY) shares rose 0.89% or +0.10 points in order to take the company’s stock at the price of $11.36. Stock’s price oscillated between $11.47 and $11.27 for intra-day trading. Relative strength index (RSI-14) for Cypress Semiconductor Corporation (NASDAQ:CY) is at 65.46. It has total market capitalization of $3.66B.

Historically the stock has climbed 7.88% in the past week and soared 11.40% in the last four weeks, the stock illustrate that its three months performance stands at 38.02% while its year to date performance is at 18.73%. The stock hit the peak level of one year at $12.46 and touched the minimum level of $6.30. Shares are trading -4.33% off from the 52-week high and +84.88% above from the 52-week bottom level. The stock is now trading at a distance of 11.19% from SMA-20. The stock is presently trading 13.06% above from its SMA-50. In the current trading session, the stock’s price moved 25.60% above from its SMA-200. The company has a Return on Assets of -5.90%. The company currently has a Return on Equity of -8.70% and a Return on Investment of -10.40%.

Cypress Semiconductor Corporation (NASDAQ:CY) on July 14, 2016 reported it will announce its second quarter 2016 earnings on Thursday, July 28, 2016 after the U.S. stock markets close and will discuss the results in a conference call that day at 1:30 p.m. Pacific Daylight Time.

Founded in 1982, Cypress is the leader in advanced embedded system solutions for the world’s most innovative automotive, industrial, home automation and appliances, consumer electronics and medical products. Cypress’s programmable systems-on-chip, general-purpose microcontrollers, analog ICs, wireless and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and get them to market first. Cypress is committed to providing customers with the best support and engineering resources on the planet enabling innovators and out-of-the-box thinkers to disrupt markets and create new product categories in record time.

Trader’s Roundup: Allergan plc Ordinary Shares (NYSE:AGN), Incyte Corporation (NASDAQ:INCY)

Allergan plc Ordinary Shares (NYSE:AGN) shares went up 0.08% or +0.19 points to reach at $242.51 during the course of session. The stock has total market worth of $95.93B and it has total of 395.56M outstanding shares. Relative strength index (RSI-14) for Allergan plc Ordinary Shares (NYSE:AGN) is at 59.12.

Historically the stock has climbed 0.80% in the past week and soared 1.41% in the last four weeks, the stock illustrate that its three months performance stands at 11.67% while its year to date performance is at -22.40%. Stock’s price oscillated from $340.34 to $195.50 during past twelve months. The stock is now trading at a distance of 3.58% from SMA-20. The stock is presently trading 4.23% above from its SMA-50. In the current trading session, the stock’s price moved -10.09% below from its SMA-200. If we take a look on its volatility, 1.98 percent was seen in a week and for the month it was 2.40 percent. Stock’s beta value stands at 0.68 and its ATR value is at 5.56.

Allergan plc Ordinary Shares (NYSE:AGN) on July 18, 2016 announced that it has filed with the U.S. Food and Drug Administration (FDA) the de novo application for the Oculeve Intranasal Tear Neurostimulator device. According to the FDA, this process provides a pathway for medical devices for which general and/or special controls provide a reasonable assurance of safety and effectiveness, but for which there is no legally marketed predicate device.

This handheld stimulator was investigated for temporarily increasing tear production upon activation in patients with dry eye disease due to decreased tear production. Recently Allergan announced that two pivotal trials of the Oculeve Intranasal Tear Neurostimulator each met their effectiveness endpoints.

“The Oculeve Intranasal Tear Neurostimulator is an exciting potential option for patients suffering from dry eye disease, and we are pleased to have filed the de novo application with FDA that will allow patients to gain access to this novel medical device,” said David Nicholson, Chief R&D Officer, at Allergan.

The Oculeve Intranasal Tear Neurostimulator will complement Allergan’s robust existing dry eye portfolio and provide physicians with a significant opportunity to treat more patients through this novel, device-based approach.

Incyte Corporation (NASDAQ:INCY) shares rose 2.06% or +1.69 points in order to take the company’s stock at the price of $83.83. Relative strength index (RSI-14) for Incyte Corporation (NASDAQ:INCY) is at 57.27. It has total market capitalization of $16.05B.

Historically the stock has slipped -2.18% in the past week and soared 5.51% in the last four weeks, the stock illustrate that its three months performance stands at 7.78% while its year to date performance is at -22.70%. The stock hit the peak level of one year at $133.62 and touched the minimum level of $55.00. Shares are trading -37.26% off from the 52-week high and +52.42% above from the 52-week bottom level. The stock is now trading at a distance of 4.43% from SMA-20. The stock is presently trading 5.71% above from its SMA-50. In the current trading session, the stock’s price moved -4.79% below from its SMA-200. The company has a Return on Assets of 4.90%. The company currently has a Return on Equity of 36.10% and a Return on Investment of 6.30%.

Incyte Corporation (NASDAQ:INCY) on July 13, 2016 announced that the National Committee for Quality Assurance (NCQA) has proposed to broaden the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening to include Cologuard on a three-year schedule.

“Inclusion in the HEDIS quality measures is an important milestone toward Cologuard becoming a standard of care for colon cancer screening,” said Kevin Conroy, chairman and CEO of Exact Sciences.  “Physicians, health systems and insurers would receive quality credit for using this patient-friendly screening option, which we believe will hasten its adoption.”

More than 90 percent of America’s health plans measure quality based on HEDIS. Likewise, the CMS Star Ratings, which guides quality measures for Medicare Advantage plans, are directly impacted by HEDIS. The proposal to broaden the colorectal cancer screening measure is subject to a 30-day public comment period, which opened on July 13, 2016.  NCQA’s effort would align HEDIS with the preeminent colorectal cancer screening recommendations, including those of the U.S. Preventive Services Task Force. The HEDIS 2017 quality measures will be used to audit the 2016 performance of physicians, health systems and insurers.